UK says alternative to AstraZeneca vaccine advised for under-30s
Despite being ‘vanishingly rare’, serious brain blood-clotting has occurred in some who have received this Covid-19 shot
07 April 2021 - 17:59
London — Britain should give an alternative to Oxford-AstraZeneca’s Covid-19 vaccine to under-30s where possible due to a “vanishingly” rare side effect of blood clots in the brain, Britain’s vaccine advisory committee said on Wednesday.
Safety concerns have prompted more than a dozen countries in recent weeks to suspend use of the vaccine, which has been given to tens of millions of people in Europe, after reports linking it to a brain blood-clotting disorder in a few dozen recipients...
Would you like to comment on this article?
Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Commenting is subject to our house rules.
BL Premium
This article is reserved for our subscribers.
A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
Already subscribed? Simply sign in below.
Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now